1Sampline RE. The Practice Parameters Committee of the American College of Gastroenterology : Practice guidelines on the diagnosis, surveillance, and therapy of Barrett' s esophagus [ J ]. Am J Gasteoenterol, 1998,93 : 1028 - 1032.
2Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States [ J ]. Cancer, 1998,83:2049 - 2053.
3Bas PL,Wijnhoven MD, Hugo W,et al. Molecular Biology of Barrett's Adenocarcinoma[ J]. Ann Surg ,2001,233:322 - 337.
4Cossentino MJ , Wong RK. Barrett's esophagus and risk of Esophageal adenocarcinoma [ J ]. Semin Gastrointest Dis, 2003,14 : 128 - 135.
5Cameron AJ, Lomboy CT, Pera M, Carpenter HA. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus[ J ]. Gastroenterology, 1995,109 : 1541 - 1546.
6Andreollo NA, Michelino MU, Brandalise NA, et al. Incidence and spidemiology of Barrett's wpithelium at the Gastrocentro -UNICAMP[ J]. Arq Gastroenterol, 1997,34:22 - 26.
7Maxdonald CE,Wicks AC, Playford RJ. Ten years experience of screening patients with Barrett's esophagus in a university teaching hospital [ J ]. Gut, 1997,41:303 - 307.
8Yehe, Hsu CT, Ho AS ,et al. Esophagitis and Barrett's esophagus in Tai Wan : a high frequency than expected [ J ]. Dig Dis Sci, 1997,42 : 702 - 706.
3[1]Spechler SJ,Robbins HB,et al.Adenocarcinoma and Barrett＇s esophagus[J].An overrated risk?Gastroenterology 1998,87∶927-933.
4[2]Miros.M,Kerlin.P.Only patients with dysplasia progress to adenocarcinoma in Barrett＇s esophagus[J].Gut,1991,32∶1441-1446.
5[3]Blot,WJ,Devesa SS.Rising incidence of adenocarcinoma of the esophagus and gastric cardia[J].J Am Med Assoc.1991,265∶1287-1289.
6[4]Silverberg Boring CC.Cancer statistics[J].CA Cancer J Clin.1990,40∶9-27.
7[5]Jankowski J,Wright N,et al.Molecular evolution of the metaplasia dysplasia adenocarcinoma sequence in the esophagus[J].AM J Pathol.1999,154∶965-973.
8[6]Brian J,Carissa A,et al.Barrett＇s esophagus:cell cycle abnormalities in advancing stages of neoplastic pogression[J].Gasreoenterology.1993,105∶119-129.
9[7]Brito MJ,Filipe MI.Association of transforming growth factor alpha and its precursors with malignant change in Barrett＇s epithelium:Biological and clinical variables[J].Int J Cancer.1995,00∶27-32.
10[8]Janusz A.Jankowski,NickA.Wright.Molecular evolution of the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus[J].Am.J.of Pathology.1999,154∶965-973.
4Buttar NS, Wang KK. Mechanisms of disease : Carcinogenesis in Barrett's esophagus [ J ]. Nat Clin Pract Gastroenterol Hepato1,2004,1 ( 2 ) : 106-112.
5Wang KK, Sampliner RE, Practice Parameters Committee of the American College of Gastroenterology. Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett' s esophagus [ J ]. Am J Gastroenterol, 2008, 103 ( 3 ) :788-797.
6Ragunath K, Krasner N, Raman VS, et al. A randomized, prospective cross over trial comparing methylene blue directed biopsy and conventional random biopay for detecting intestinal metaplasia and dysplasia in Barretts' esophagus[ J]. Endoscopy ,2003,35 ( 12 ) :998-1003.
7Guelrud M, Ehrlich EE. Endoscopic classification of Barrett's esophagus [ J ]. Gastrointest Endosc, 2004,59 ( 1 ) : 58-65.
8Endo T, Awakawa T, Takahashi H, et al. Classification of Battett' s epithelium by magnifying endoscopic [ J ]. Gastrointest Endosc ,2002,55 (6) :641-647.
9Ginsberg GG. Endoscopic approaches to Aarrttt' s oesophagus with high-grade dysplasia early mucosal cancer [ J]. Best Pract Res Clin Gastroenterol, 2008, 22 (4): 751-772.
10. v Polglase AL, McLaren WJ, Skinner SA, et al. A fluorescence confocal endom icroscope for invivo microscopy of the upper and lower G I tract[ J ]. Gastrointest Endosc, 2005,62 (5) : 686-695.
